CASI Pharmaceuticals, Inc.
CASI
$0.94
$0.010.88%
NASDAQ
| 09/30/2025 | 03/31/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -77.49% | -35.42% | -47.70% | -47.70% | -41.53% |
| Total Receivables | -76.59% | 25.29% | 51.36% | 51.36% | -4.40% |
| Inventory | -79.80% | -73.07% | -66.92% | -66.92% | 46.38% |
| Prepaid Expenses | -11.45% | 35.33% | 12.81% | 12.81% | 11.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -74.73% | -37.05% | -33.31% | -33.31% | -18.87% |
|
|
|||||
| Total Current Assets | -74.73% | -37.05% | -33.31% | -33.31% | -18.87% |
| Net Property, Plant & Equipment | -19.78% | 0.68% | -2.35% | -2.35% | 16.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -79.95% | -85.65% | -87.06% | -87.06% | 309.16% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.98% | -15.95% | -23.37% | -23.37% | -56.53% |
| Total Assets | -61.55% | -29.63% | -28.69% | -28.69% | -14.30% |
|
|
|||||
| Total Accounts Payable | -68.25% | 104.97% | -38.64% | -38.64% | -31.17% |
| Total Accrued Expenses | 54.19% | 76.18% | 18.47% | 18.47% | 40.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 2,593.13% | 2,593.13% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 28.16% | 28.16% | -- |
| Total Other Current Liabilities | -- | -- | 28.16% | 28.16% | -- |
| Total Current Liabilities | 167.46% | 294.58% | 117.94% | 117.94% | 24.62% |
|
|
|||||
| Total Current Liabilities | 167.46% | 294.58% | 117.94% | 117.94% | 24.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 56.87% | 56.87% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -14.30% | -1.53% | -7.43% | -7.43% | 32.92% |
| Total Liabilities | 6.60% | 14.92% | 1.41% | 1.41% | 109.17% |
|
|
|||||
| Common Stock & APIC | 1.21% | 2.59% | 2.52% | 2.52% | 2.43% |
| Retained Earnings | -7.20% | -6.04% | -5.94% | -5.94% | -4.58% |
| Treasury Stock & Other | -12.99% | -10.50% | -5.31% | -5.31% | -16.25% |
| Total Common Equity | -306.49% | -152.18% | -92.34% | -92.34% | -51.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -306.49% | -152.18% | -92.34% | -92.34% | -51.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -306.49% | -152.18% | -92.34% | -92.34% | -72.54% |
|
|
|||||